CD34 and breast carcinoma: Besides, western blot and immunohistochemistry assays indicated that RLT-03 significantly inhibited the expression of VEGF, EGF, CD34, IL-10, and TGF-β related to the angiogenesis and inflammatory regulation of breast cancer.